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The effect of resveratrol on the expression of MDR1 gene 
in leukemic lymphoblast’s of acute lymphoblastic leukemia 
patients 
 
 
Abstract 
Background: Chemotherapy plays a very important role in the treatment of leukemia but 
the resistance properties of the lymphoblasts limit the effect of chemotherapy. One of the 
main mechanisms of resistance to chemotherapy is the increased expression of MDR1 
gene. The aim of this study was to explore the effect of resveratrol on the expression of 
MDR1 gene in leukemic lymphoblast of new cases of acute lymphoblastic leukemia 
(ALL) patients in vitro. 
Methods: Separation of lymphoblasts of 5 new case ALL patients from peripheral blood 
was performed by ficoll density gradient centrifugation. Lymphoblasts were cultured in 
RPMI 1640 medium. Lymphoblasts were treated with 50µmol/L resveratrol for 48 h. Total 
RNA was extracted with guanidine isothiocyanate. RNA was converted to cDNA. Real 
time PCR was used to detect mRNA expression of MDR1. 
Results: The results of gene detection showed that the expression of MDR1 did not change 
significantly in the patients however, in one patient expression of MDR1 increased upon 
treatment with resveratrol. 
Conclusion: The results of this study did not support resveratrol as a compound to reverse 
multidrug resistance in leukemic lymphoblasts. 
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Acate lymphoblastic leukemia (ALL) is the most common malignancy in children 
(1). Chemotherapy has an important role in the treatment of malignancies, but resistance 
properties of lymphoblasts may decrease the effect of chemotherapy. Lymphoblasts can 
develop resistance to the drugs used in chemotherapy. Furthermore, some leukemia 
become resistant to other drugs that their functions are not related. This phenomenon is 
multidrug resistance (MDR) (2). P-glycoprotein which is an ATP binding glycoprotein is 
organized in two transmembrane domains and coded by the MDR1 gene (3, 4). The 
hydrolysis of ATP enables the conformational changes in P-glycoprotein leading to the 
extrusion of drugs out of the cell (4).Some natural and synthetic substances have been 
tested to overcome multidrug resistance(5). These include calcium channel blockers 
(verapamil) (6). However, these substances were not successful in clinical practice because 
of their severe side effects in vivo (7). Resveratrol acts as anti-inflammatory drug in the 
form of powdered root Polygonum cuspidatum (8). Resveratrol prevents plants from being 
aggressive by fungal and other forms. The skin of the grape contains higher level of 
resveratrol (9). 
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Resveratrol has a dose-dependent effect on mitotic and 
apoptotic activity of endothelial and tumor cell lines, while 
the low dose of resveratrol enhance cell proliferation; higher 
doses induce apoptosis and decrease mitotic activity (10). 
Resveratrol is known to have potent anti-inflammatory and 
antioxidant effects and inhibits the growth of a variety of 
cancer cells (11). In this research, we evaluated the effect of 
resveratrol on the expression of MDR1 gene in leukemic 
lymphoblast’s of new case ALL patients in vitro. 
 
 
Methods 
5 new ALL patient cases were enrolled in the study after 
filling out the informed consent form. All patients had more 
than 100x10³/µl white cells in peripheral blood with up to 
80% blasts. Samples were obtained before starting 
chemotherapy. Mononuclear cells were separated from 3ml 
of peripheral blood of the patients with the use of fycol and 
centrifuge. 
Cell culture: Cells were grown in RPMI 1640 medium 
(Gibco, Invitrogen, USA), under sterile condition. Cells were 
incubated in a humidified 5% CO2 incubator at 37°C. The 
lymphoblasts of each patient were divided into two parts and 
cultured in separated cell culture T-25 flasks in which one of 
them was the group treatment with resveratrol and the 
control group. 
Treatment of the cells with resveratrol: Resveratrol with 
the concentrations of 50 moll/L was added to the flasks 
then incubated in 37°C and 5% CO2 incubator. After 48 h of 
incubation, the total RNA was extracted then reversely 
transcribed into cDNA using an ExScriptRT reagent kit 
(Bioneer).  primers: MDR1(87bp) sense 5´-
CGGGAGCAGTCATCTGTGGT-3´ antisense 5´-
CAAAGAGAGCGAAGCGGCTG-3´; β-actin (160 bp) sense 
5´-AGA ACA TCA TCC ATG CAT CCA-3´, antisense 5´-GCC 
TGC TTC ACC ACC TTC TTG-3´. Real time-PCR conditions 
were set as follows: 94° C for 10 min, 45 cycles at 94 °C for 
30 s, 58 °C for 30 s, and 72° C for 35 s; followed by 
extension at 72 °C for 10 min. All the data were processed 
with SPSS13.0. One-factor variance analysis (ANOVA) was 
used in the comparison of several concentrations and the 
significance of difference was indicated as p<0.05. 
 
 
Results 
The relative expression of MDR1 gene was analyzed by  
Real-time-PCR. After 48 h treatment with 50 µmol/L of 
resveratrol, the expression of MDR1 gene was not changed 
significantly in lymphoblasts in 4 patients and was in the 
range of 1.087 to 1.3 times, but in one patient increased upon 
treatment (3.335 times) (fig 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Effect of resveratrol on the expression of MDR1 
gene in leukemic lymphoblasts 
 
 
Discussion 
MDR1, express P-glycoprotein, a transmembrane carrier 
that exports hydrophobic substrates and most chemotherapy 
drugs out of the cells especially tumor cells. A growing body 
of literature indicates that resveratrol, a plant constituent 
enriched with the skin of grapes (12), is one of the promising 
agents for the prevention of heart disease. Similarly to other 
polyphenols resveratrol exerts an antioxidant effect (13). In 
addition resveratrol acts as an antioxidant (10, 14). 
Belaszenda demonstrated that resveratrol has a dose-
dependent effect on mitotic and apoptotic activity of 
endothelial and tumor cell lines. They showed that low doses 
of resveratrol enhance cell proliferation; higher doses induce 
apoptosis and decrease mitotic activity. Fang Guan assessed 
the effect of resveratrol on the expression of MDR1 gene in 
human oral epidermis KBv200 cell line and showed that 
resveratrol could down-regulate MDR1 gene (15). But the 
results of our study showed that the expression of MDR1 
gene was not changed significantly in the lymphoblasts of 4 
patients and in one patient increased upon treatment. The 
reason for these unexpected results is not entirely clear. It 
may also be because the concentration used for treatment, 
was low. Also 48 h treatment with resveratrol may be not 
 Caspian J Intern Med 2015; 6(2): 113-115 
Resveratrol effects on the MDR1 gene in the ALL patients                                                                                                                                                           115 
sufficient for resveratrol to take effect on gene expression. 
Furthermore, we supplemented the culture medium with fetal 
bovine serum which may interfere with gene expression. 
Furthermore, the MDR1 gene expression in one patient is 
very high in comparison to other patients as you can see in 
figure 1 (3.335 times). This high change may be the under 
effect of genetic differences or special translocations. 
Resveratrol may have different effects in the upper 
concentrations that need to be assessed in the future. 
In conclusion, we did not find any sign in support of 
resveratrol as a compound reversing multidrug resistance in 
leukemic lymphoblasts. 
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